Cocrystal Pharma, Inc. (COCP) vs Citius Pharmaceuticals, Inc. (CTXR)

A side-by-side comparison of Cocrystal Pharma, Inc. and Citius Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COCP vs CTXR

growth of $100 · dividends reinvested · last 10y
COCP -99.4% (-39.6%/yr)CTXR -99.8% (-45.7%/yr)COCP compounded faster over this window
050100Start $10020182020202220242026$1$0
COCP CTXR

COCP vs CTXR: by the numbers

  • •COCP is the larger company ($15M vs $14M market cap).
  • •Both run net losses; CTXR's is the smaller (-651.27% vs -3011.52% net margin).

Metrics side by side

Valuation

MetricCOCPCTXR
P/S ratio46.221.94
P/B ratio14.610.21

Profitability

MetricCOCPCTXR
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin-3011.52%-651.27%
ROE-951.92%-69.47%
ROIC-497.29%-67.62%

Growth (annualized)

MetricCOCPCTXR
Revenue CAGR (5Y)91.55%N/A
Total return CAGR (5Y)-37.50%-60.04%

Frequently asked

How have COCP and CTXR total returns compared?
Over the past 10 years, COCP delivered -39.76% and CTXR delivered -46.34% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.